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Abstract
Background: The PD COMM trial is a phase III multi-centre randomised controlled trial whose aim is to evaluate
the effectiveness and cost-effectiveness of two approaches to speech and language therapy (SLT) compared with
no SLT intervention (control) for people with Parkinson’s disease who have self-reported or carer-reported problems
with their speech or voice. Our protocol describes the process evaluation embedded within the outcome evaluation
whose aim is to evaluate what happened at the time of the PD COMM intervention implementation and to provide
findings that will assist in the interpretation of the PD COMM trial results. Furthermore, the aim of the PD COMM process
evaluation is to investigate intervention complexity within a theoretical model of how the trialled interventions might
work best and why.
Methods/design: Drawing from the Normalization Process Theory and frameworks for implementation fidelity, a mixed
method design will be used to address process evaluation research questions. Therapists’ and participants’ perceptions
and experiences will be investigated via in-depth interviews. Critical incident reports, baseline survey data from therapists,
treatment record forms and home practice diaries also will be collected at relevant time points throughout the running
of the PD COMM trial. Process evaluation data will be analysed independently of the outcome evaluation before the two
sets of data are then combined.
Discussion: To date, there are a limited number of published process evaluation protocols, and few are linked to trials
investigating rehabilitation therapies. Providing a strong theoretical framework underpinning design choices and being
tailored to meet the complex characteristics of the trialled interventions, our process evaluation has the potential to
provide valuable insight into which components of the interventions being delivered in PD COMM worked best (and
what did not), how they worked well and why.
Trial registration: ISRCTN Registry, ISRCTN12421382. Registered on 18 April 2016.
Keywords: Process evaluation, Complex interventions, Speech and language therapy, Lee Silverman Voice Treatment,
Fidelity
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Background
PD COMM trial
Parkinson’s disease (PD) is one of the most common ser-
ious movement disorders in the world [1, 2], affecting ap-
proximately 120,000 people in the United Kingdom alone
[3]. Speech impairments, which affect a large proportion
of the PD population, have been recognised to reduce
these individuals’ quality of life [4, 5]. The PD COMM
trial is a phase III, multicentre, three-arm, unblinded ran-
domised controlled trial (RCT) whose aim is to evaluate
the effectiveness, cost-effectiveness and implementation
process of two types of speech and language therapy (SLT)
compared with no treatment (control) for people with PD
who have self-reported problems with their speech or
voice. It will also compare the two types of SLT (Lee Sil-
verman Voice Treatments [LSVT] versus NHS standard
SLT). Results derived from a pilot trial (PD COMM Pilot)
informed the design of this RCT (Sackley et al: Lee Silver-
man voice treatment versus standard speech and language
therapy versus control in Parkinson’s disease: a pilot ran-
domised controlled trial, submitted); a full description of
the pilot trial is provided elsewhere [6].
Although a Cochrane review was unable to support the
efficacy of any form of SLT over another, owing to small
participant numbers and methodological flaws in trials [7],
LSVT is regarded as the most efficacious treatment for
communication impairments in patients with PD [8]. Its
aim is to improve phonation and vocal loudness through
better vocal fold adduction [9]. As recommended by the
originators, LSVT will be administered in four 50-minute
sessions per week for 4 weeks. Each session will consist of
25 minutes of repeated and intensive maximum-effort
drills and 25 minutes of high-effort speech production
tasks [9]. Participants will be asked to complete up to
10 minutes of home-based practice/tasks on treatment
days and up to 30 minutes on non-treatment days [10].
The second trial intervention, NHS standard SLT, will be
individualised to suit the needs of each participant and
will reflect local practice. Thus, its dose and frequency will
be more variable, but it will likely consist of one session
per week for 6–8 weeks of varying content which may in-
clude behavioural compensatory strategies and augmenta-
tive and alternative communication strategies to improve
functional communication and participation [11].
Investigating the complexity of PD COMM interventions
via process evaluation
This paper describes the protocol for the process evaluation
that is being conducted alongside the outcome evaluation
as part of the PD COMM trial. In order to assess fidelity,
this process evaluation will be focused on investigating the
quality of implementation of the PD COMM interventions
as well as adherence to the outcome evaluation protocol.
As the Medical Research Council guidance [12, 13] states,
process evaluations serve a vital role because they are fo-
cused on identifying the underpinning characteristics of
intervention components and how these impact delivery of
the intervention to a set standard. They also provide de-
tailed insight into the experiences of those who engage with
the complex intervention [14, 15]. Critically, by carrying
out a process evaluation, it is possible to identify if observed
impacts are due solely to the trial intervention or are a re-
sult of a number of external and internal variables that are
closely linked to the environment and the context in which
the interventions take place [15–18]. Finally, complex trials
such as PD COMM which include a process evaluation will
produce higher-quality results that not only can improve
theory-informed rehabilitation interventions but also help
increase their potential generalizability and optimisation in
routine practice [19, 20].
In order to identify the causal processes taking place dur-
ing the PD COMM trial, this process evaluation has used
the Normalization Process Theory (NPT), which is highly
attuned to the challenges of complex interventions [21].
This theory provides a robust analytical framework to
examine how speech and language therapists as well as
trial participants embed and integrate (sustain) PD COMM
interventions into their routine practice and daily life, re-
spectively [22]. This framework [23] explains how this is
accomplished through four generative mechanisms (coher-
ence, cognitive participation, collective action and reflexive
monitoring). By using the NPT framework, we consider
that we can explore, describe and understand the processes
that are taking place and the interactions and gaps between
the PD COMM interventions, the changing context,
speech and language therapists and their practice.
Aims and objectives
The overall aim of this process evaluation is to evaluate
and understand what worked and why at the time of the
PD COMM intervention implementation and to provide
findings that will assist in the interpretation of the PD
COMM trial results. Specific objectives are as follows:
1. Establish a programme theory that explains how the
PD COMM complex interventions are expected to
work to generate outcomes amongst a complex patient
group. This programme theory will consist of a set of
tangible assumptions that reflect the multi-component
nature of the PD COMM interventions. It will further
be used to guide the analysis and synthesis of data.
2. Investigate the implementation of trial interventions
from the perspective of therapists. This will include
attention to previous experience, level of acceptance
of the interventions, and therapists’ expectations.
3. Investigate study participants’ experiences and views
about their involvement in the PD COMM study,
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identifying factors shaping and differentiating life with
PD, participation, motivation, and (where relevant)
adherence to therapy for those in the treatment and
control groups.
Methods/design
The process evaluation will be conducted as an integral
part of the PD COMM trial and will use NPT to examine
normalisation from the perspectives of both staff delivering
the intervention and patient participants who need to
embed the trial interventions into their daily routines. A re-
search officer will lead the work as part of a small sub-team
of process evaluation researchers who will monitor its pro-
gress and contribute to the ongoing data analysis. Through-
out the PD COMM trial, the process evaluation team will
also be in regular contact with LSVT developers in order to
discuss adherence to LSVT protocols and quality of imple-
mentation. A mixed method design will be used to address
research objectives. This will involve the integration of both
qualitative and quantitative data in the research process.
Data collection
We will employ a number of approaches to data collec-
tion during the PD COMM process evaluation in order
to answer our research questions (Tables 1 and 2).
Therapist questionnaire
All speech and language therapists and SLT assistants
involved in the trial will be asked to complete an online
questionnaire at two time points: prior to the start of
intervention delivery and after they have treated their
last PD COMM participant. Guided by the NPT con-
structs [23, 24], this questionnaire (see Additional file 1)
includes three sections with a series of Likert scale ques-
tions which will explore the following:
1. Therapists’ role within their service, previous experience
as speech and language therapists and SLT assistants
delivering LSVT and NHS standard therapy, and
information on relevant training
2. Therapists’ understanding of LSVT and NHS standard
therapy interventions and their familiarity in their
implementation, both at a personal level and in terms
of the working context; also included are therapists’
expectations in regard to their ability to carry out
their research role, being aware of potential deviations
from their usual ways of working
3. Therapists’ opinions on how they feel their skills
have developed in regard to delivering LSVT and
NHS standard therapy
In order to measure therapists’ self-belief, the ques-
tionnaire includes the Generalized Self-Efficacy Scale
[25] in one of its sections. The last part of the therapist
questionnaire is an LSVT practice checklist (copyright
2014 by LSVT Global, Inc., Tucson, AZ, USA) which
has been created by the intervention developers and is
divided into eight sections outlining the LSVT interven-
tion. This skills checklist will provide valuable insight
into therapists’ level of confidence in their ability to de-
liver all components of LSVT.
Observations of therapists’ training and trial workshops
Observations by the process evaluation research officer
will be made during the LSVT training and certification
courses, which will be offered to both new and previously
certified clinicians prior to their involvement in the PD
COMM trial. The views of LSVT intervention developers
providing the training will also be recorded on the day of
the training. Furthermore, all other workshops organized
by the trial researchers with network therapists will be ob-
served. The purpose of these workshops will be to help
build a network of research therapists and generate enthu-
siasm around engagement with PD COMM. Therapists,
research nurses and researchers attending the workshops
will be able to voice their concerns and discuss potential
Table 1 Data collection methods and time points
Data collection method Time points
Therapist questionnaire (TQ) Prior to start
After therapists have treated their last PD COMM participant
Observations of therapists’ LSVT training and additional workshops
organized by the trial researchers
Prior to start
Yearly workshops
Semi-structured in-depth interviews
• With participants After 3-month assessment
• With speech and language therapists and SLT assistants Two time points: midway and at the end of therapists’ involvement in the trial
Critical incident reports (CIRs) Throughout therapists’ involvement in the trial
SLT treatment record form (SLT TRF) Every therapy session
Standard NHS SLT home-based therapy (HBT) diary Completed when home-based therapy is prescribed by speech and language therapists
LSVT home-based therapy (HBT) diary Completed once for each of the 4 weeks of LSVT
LSVT Lee Silverman Voice Treatments, SLT Speech and language therapy
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strategies to address barriers to implementation. It is an-
ticipated that one event per year will be scheduled
throughout the running of the trial. These observations
will provide substantial data on the therapists’ level of in-
volvement and engagement in the trial. During the obser-
vations, the research officer will make field notes guided
by Spradley’s [26] work, which identifies nine dimensions
of descriptive observation and encourages the researcher
to focus on things that are not necessarily visible. Particu-
lar attention will be given to issues centred on goal setting,
skill acquisition and competence.
Semi-structured in-depth interviews
Study participants Face-to-face qualitative interviews
will be conducted with a purposive sample of 20 partici-
pants in each of the 3 trial arms. Sampling will ensure
Table 2 Data sources used to address PD COMM process evaluation objectives and analytical questions
Objectives Analytical questions Data sources
Establish a programme theory that explains how PD
COMM interventions are expected to work
What are the components of the PD COMM interventions? Which are
core? Which are peripheral?
What are the interactions between the components of the PD COMM
interventions?
OBS, TQ, therapists’
interviews, TRF, HBT diaries
Investigate the implementation of trial interventions
from the perspective of therapists
What were therapists’ opinions of the PD COMM interventions? Therapists’ interviews, CIRs,
OBS
What experience of delivering the PD COMM interventions did the
therapists have prior to the start of the trial?
TQ, therapists’ interviews
What were therapists’ motivations for joining the trial? TQ, therapists’ interviews
To what extent did the training help therapists ‘feel ready’? OBS, therapists’ interviews
How did ‘learning time’ impact the way therapists delivered the PD
COMM interventions?
TQ, therapists’ interviews,
TRF
To what extent did therapists feel supported in their role as
research therapists?
TQ, therapists’ interviews,
CIRs
What challenges did therapists face? How did they manage them? OBS, therapists’ interviews,
CIRs
How did therapists feel about the way they recorded content and
results from therapy sessions?
Therapists’ interviews, TRF
How did therapists work on building rapport with participants? Therapists’ interviews, TRF,
CIRs
How did the PD COMM interventions compare with the therapists’
routine way of practicing?
TQ, therapists’ interviews,
CIRs
What are the therapists’ views regarding the resources allocated to
the trial?
TQ, therapists’ interviews
How have therapy outcomes impacted the therapists’ level of
motivation/engagement?
Therapists’ interviews, CIRs
To what extent did therapists tailor the PD COMM interventions to
participants’ needs?
TQ, therapists’ interviews,
TRF, CIRs, HBT diaries
How did therapists feel about their research role versus their client-
centred approach to practice?
Therapists’ interviews, CIRs
To what extent did therapists follow the trial intervention protocol? TQ, therapists’ interviews,
TRF
To what extend did therapists feel supported by their environment? TQ, therapists’ interviews,
CIRs
Investigate participants’ experiences and views
about their involvement in the PD COMM trial
To what extent did participants engage in the trial? Participants’ interviews, HBT
diaries
What did participants think of their involvement in the trial? Participants’ interviews
How did the therapy sessions impact their everyday routine? Participants’ interviews, HBT
diaries
What were participants’ motivations for joining the trial? Participants’ interviews
Can participants identify positive/negative impacts of their
involvement in the trial?
Participants’ interviews
Abbreviations: CIR Critical incident report, HBT Home-based therapy, LSVT Lee Silverman Voice Treatments, OBS Observations of Lee Silverman Voice Treatments
training and trial workshops, SLT Speech and language therapy, TQ Therapist questionnaire, TRF Treatment record form
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engagement of trial participants with different ages and
PD severities (Hoehn & Yahr stage) as well as the pres-
ence of a family carer. Participants will be invited to take
part in the interview at a time and place that suits them.
Interviews should last no longer than 30 minutes. All
participants will be given an information sheet and will
be asked to sign a consent form prior to the interview.
Interviews will take place after the three month assess-
ment, and will draw on an interview spine underpinned
by both the NPT analytical framework [23] and the PD
COMM intervention programme theory (see Additional
file 2). By being focused on the work associated with as-
similating new interventions into pre-existing norms and
routines, the use of this theoretical perspective will enable
the differentiation of managing life with PD in general and
speech and therapy interventions in particular.
Study therapists Semi-structured in-depth interviews
will be conducted with speech and language therapists
and SLT assistants delivering the two active treatment
arms. The programme theory will guide questions ex-
ploring issues linked to the implementation of this com-
plex intervention from the therapists’ perspectives. The
structure and content of these interviews will similarly
reflect the four mechanisms described in the NPT ana-
lytical framework [23] in order to understand the work
of therapists in delivering and embedding the interven-
tion in their routine practice. All participants will be
asked to give consent to the recording prior to the start
of the interview, which will be carried out over the
phone at a convenient date and time. Interviews are esti-
mated to last a maximum of 1 h. All interviews will be
digitally recorded and fully transcribed and then checked
by the interviewer, keeping all names of participants an-
onymous. As a recommended quality assurance meas-
ure, transcripts will be made available to all participants
(member checking) as a way to ensure the validity and
accuracy of findings [27]. Therapists will also be given
the opportunity to provide subsequent reflections if they
consider them necessary.
Interviews will be carried out at two time points: ap-
proximately midway through therapists’ involvement in
the trial and at the end of their involvement, once they
have treated their last PD COMM participant. This will
be essential in order to discern the impact that learning
over time might have on therapists’ role in delivering the
PD COMM interventions. Prior to the interview, written
information will be sent to all speech and language ther-
apists via an email explaining the aims of the process
evaluation and the reasons underlying the importance of
collecting data via individual interviews. Therapists will
be encouraged to talk openly and discuss failures and
problems as well as successes. If they wish, they can also
talk more abstractly about what might have occurred
had things been different. For a copy of the interview
schedule, see Additional file 3.
Critical incident reports
All therapists will be asked to record key reflections using
a critical incident technique [28]. Data will be collected in
the form of critical incident reports (CIRs) and will follow
Gibbs’s [29] reflective cycle. (A copy of the CIR form is
provided in Additional file 4.) Guiding questions in the
form are designed to encourage therapists to examine
their own assumptions and beliefs as well as the reasoning
and values underpinning their practice [30]. The aim is to
further investigate the sense that therapists make of par-
ticularly challenging or memorable situations that take
place during their involvement in the PD COMM trial.
CIR data will reveal therapists’ ‘theories in use’ rather than
any espoused practice to conform to researchers’ expecta-
tions of their work within the trial. Speech and language
therapists and SLT assistants will be briefed regarding the
purpose and content of CIRs and will be asked to submit
their completed forms by post or by email throughout
their involvement in the trial. Reminder emails will be sent
to the therapists in order to encourage completion.
SLT treatment record form
All speech and language therapists and SLT assistants in-
volved in the PD COMM trial will be asked to complete
an SLT treatment record form (TRF). This record repre-
sents a data source from the outcome evaluation which
will be further used for the purpose of the process evalu-
ation. In this SLT TRF, therapists working in each of the
study sites will record the number of minutes they dedi-
cate to various aspects of the PD COMM interventions
at each therapy session.
These SLT TRFs will be used to monitor participant
adherence (e.g., missed or cancelled appointments) and
therapist adherence to the protocols for these pro-
grammes. In addition, for the standard SLT intervention,
the forms will be used to further explore what standard
SLT delivered within the NHS entails.
Home-based therapy diaries
Participants in each of the intervention arms will be
asked to complete home-based therapy (HBT) diaries.
Those participants receiving LSVT will be asked to
complete an LSVT HBT diary for each week of treat-
ment. Each diary is used to record information for 7 days
of home LSVT practice exercises. Those participants
receiving standard NHS SLT will be asked to complete a
diary as and when they are prescribed home-based exer-
cises by their therapist. These HBT diaries will measure
the amount of intervention practice that participants
complete outside formal intervention delivery sessions.
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Data analysis
The analysis and synthesis of data will be driven by the
programme theory that explains the PD COMM inter-
ventions and their impact over time. Both qualitative
and quantitative methods will be used to describe the
multiple, multi-level, interacting components within and
across both PD COMM intervention arms. Although
components of the intervention are well specified in
LSVT, in NHS standard SLT they are not, as reported in
the PD COMM Pilot [6].
Quantitative data
Both intervention adherence and intervention logic re-
quire a traditional approach to data analysis, being fo-
cused on within- and between-group comparisons. The
heterogeneity and lack of a benchmark for standard
NHS SLT places limits on the extent to which adherence
and quality of implementation (fidelity) can be moni-
tored. However, data derived from the SLT TRF and the
HBT diaries will allow the process evaluation team to
describe the following statistically within and between
each intervention arm:
 What NHS standard SLT entails
 How therapists structured the intervention (including
who delivered it and where as well as how time was
reportedly allocated to different aspects specified by
the research team)
 How regularly participants attended scheduled
appointments
 How closely participants reported adhering to the
type and dosage of home practice activities agreed
between them and their therapist, and whether they
attended adjuncts to therapy such as group activities
In addition, the process evaluation team will aim to
describe statistically how the structure of intervention
content (in terms of the distribution of time spent on as-
pects specified by the research team) shifted over the
course of intervention for participants. This will be for
each intervention arm as a whole because it is not con-
sidered likely that either participating therapists or cen-
tres will have sufficient numbers of participants to
enable meaningful within-group comparisons.
The team will categorise, describe and identify trends
in the use of components of the PD COMM interven-
tions by systematically extracting data from the SLT
TRF, HBT diaries and the therapy notes, mapping the
data to the Template for Intervention Description and
Replication framework [31] and exploring these data sta-
tistically. To ensure the findings have face validity and
continue to be grounded in practice, constant feedback
from a network of participating PD COMM therapists
will be sought.
Descriptive statistics will be analysed with the data derived
from the therapist questionnaire. This will indicate the
frequency of responses to items and will show where thera-
pists have shown a more positive or negative responses.
Qualitative data
All interviews will be recorded and transcribed verba-
tim after anonymization. The Atlas.ti software package
(ATLAS.ti Scientific Software Development GmbH,
Berlin, Germany) will be used to facilitate analysis.
Intervention fidelity and complexity are associated with
different analytical approaches, which may integrate differ-
ent types of data from different sources. These analyses
are associated with the development of a theoretical un-
derstanding of issues pertinent to how the interventions
operate in the context of the clinical trial. All interview
data, CIRs and notes from observations will be coded
using a theoretical coding framework underpinned by the
PD COMM intervention programme theory and NPT
constructs [21]. The analysis will follow the phases of the-
matic analysis described by Braun and Clarke [32]. First,
two of the authors (PMA and CRB) will re-read all tran-
scripts and notes to gain familiarity with the data. The re-
searchers will then code all data informed by the coding
framework and will assign relevant data extracts to each
code. The distribution of codes will be recorded, and new
codes will be created for data falling outside the coding
framework to avoid missing important concepts. Themes
will then be identified as meaningful patterns across coded
data. Themes will then be reviewed and agreed by all au-
thors. These qualitative data analyses will be conducted
within source prior to synthesis across data sources.
Synthesis
To allow for synthesis, the initial framework of thematic
categories generated from the thematic analysis will be
applied to all data as part of the analytical approach. The
analytical task will be to describe the acceptability of
participants’ engagement with the study interventions,
differentiation of management of life with PD in general,
and speech and therapy interventions in particular. The
quantitative data on intervention delivery and adherence,
together with qualitative insights into participants’ en-
gagement in the trial, quality of implementation and
complexity issues, will be triangulated to develop an ex-
planatory account of the outcome evaluation findings.
Data analyses will be ongoing, and process data will be
analysed independently of the outcome evaluation data
before the two sets of data are then combined.
Governance
The PD COMM trial outcome and process evaluation will
be effectively integrated to avoid, for example, duplication
of effort. However, some of the process evaluation data
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collection will be carried out at ‘arm’s length’ in order to
reduce the burden on participants. Researchers at
Glasgow Caledonian University will collect and analyse
intervention component data and adherence to the pre-
scribed interventions (SLT TRF, HBT diaries and therapy
notes). Researchers from Bangor University will collect all
qualitative data, including the therapist questionnaire, in
order to investigate all aspects of quality of implementa-
tion of the PD COMM complex interventions. The
process evaluation team will produce 6-monthly reports
on progress to the trial management team.
Ethics and consent
Ethical approval for this process evaluation has been ob-
tained from the Bangor University Ethics Committee. In-
formation about the process evaluation has been included
in the PD COMM trial protocol, information sheets and
consent forms. Participants will have the option to con-
sent to be contacted regarding taking part in the process
evaluation at the time of consenting to take part in the PD
COMM trial. Ethical approval for the PD COMM trial
was given on 17 December 2015 (REC 15/WM/0443).
Discussion
Investigating fidelity via high-quality process evaluations
can increase researchers’ understanding of why a complex
intervention works or fails. To date, there are a limited
number of published process evaluation protocols, and
the number is even lower when linked to trials investigat-
ing rehabilitation therapies. Regardless of this, there has
been a significant increase in the funding allocated to
carry out process evaluations. There is no single way to
design and carry out a process evaluation [17, 33]; this is
particularly true when dealing with complex interventions
such as the ones investigated in the PD COMM trial.
Hence, the research team faced having to make choices
about what aspects of the interventions and their delivery
to focus on, as well as what methods to select in order to
address these whilst avoiding the collection of unnecessary
data at a high cost [34]. By having a strong theoretical
framework underpinning our design choices and by tailor-
ing the evaluation to meet the intrinsic characteristics of
this trial, this process evaluation can potentially lead to a
good understanding of not only how the PD COMM in-
terventions worked best and why but also for whom and
where. The aims of PD COMM are to achieve this and
bring clarity to how therapists’ learning and tailoring
throughout the implementation of a complex intervention
can impact outcomes. Rehabilitation interventions such as
PD COMM interventions are likely to be tailored as thera-
pists become more experienced and ‘learn’ how to best
target participants’ needs whilst staying true to the tri-
al’s intervention protocol. In today’s healthcare re-
search, where client-centredness plays a major role,
there is an increased awareness of the need to tailor
interventions to patients’ needs and cultural back-
grounds [35]. This process evaluation will have a role in
monitoring how this is done whilst exploring individual
contexts, and this may help to explain variations in the
effectiveness of the intervention.
Additional files
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Additional file 2: PD COMM process evaluation participant interview
schedule. (PDF 354 kb)
Additional file 3: PD COMM process evaluation therapist interview
schedule. (PDF 369 kb)
Additional file 4: PD COMM process evaluation critical incident report
form. (PDF 291 kb)
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